Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy in Low-Risk Renal Transplant Recipients: 8 Year Follow Up

被引：0
|
作者：
Laftavi, Mark R. [1 ]
Patel, Sunil [1 ]
Feng, Lin [1 ]
Said, Meriem [1 ]
Laftavi, Helia [1 ]
Kohli, Romesh [1 ]
Alnimri, Muna [1 ]
Pankewycz, Oleh [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：324 / 324
页数：1
相关论文
共 50 条
  • [1] Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up
    Laftavi, M. R.
    Alnimri, M.
    Weber-Shrikant, E.
    Kohli, R.
    Said, M.
    Patel, S.
    Pankewycz, O.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 458 - 461
  • [2] Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients
    Abou-Jaoude, MM
    Ghantous, I
    Najm, R
    Afif, C
    Almawi, WY
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2731 - 2732
  • [3] Effectiveness of Low versus Standard Dose of Rabbit Anti-Thymocyte Globulin Induction in Kidney Transplant Recipients
    Becker, K.
    Lam, I.
    Kuo, V.
    Perreiter, A.
    Dalin, M.
    Chongkrairatanakul, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S834 - S834
  • [4] Impact of Rabbit Anti-Thymocyte Globulin Induction Therapy on Reactivation of BK Virus in Renal Transplant Recipients.
    Agarwal, A.
    Metha, A.
    Kokko, K.
    Turgeon, N. A.
    Tso, P. Y.
    Newell, K. A.
    Larsen, C. P.
    Kirk, A. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 422 - 422
  • [5] Impact of rabbit anti-thymocyte globulin induction therapy on reactivation of BK virus in renal transplant recipients.
    Agarwal, A.
    Meetha, A.
    Kokko, K. E.
    Turgeon, N. A.
    Tso, P. L.
    Newell, K. A.
    Pearson, T. C.
    Larsen, C. P.
    Kirk, A. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 460 - 460
  • [6] EARLY OUTCOMES POST RENAL TRANSPLANTATION IN LOW AND MODERATE IMMUNOLOGIC RISK RECIPIENTS FOLLOWING BASILIXIMAB OR RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY
    Salehi, T.
    Clayton, P. A.
    [J]. NEPHROLOGY, 2020, 25 : 80 - 80
  • [7] Evaluation of Dose Dependent Rabbit Anti-Thymocyte Globulin Induction in Risk-Stratified Kidney Transplant Recipients.
    Gutman, I.
    Misel, M.
    Mckay, D.
    Hemming, A.
    Kerr, J.
    Mekeel, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 613
  • [8] Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients
    Belitsky, P
    MacDonald, AS
    Lawen, J
    McAlister, V
    BitterSuermann, H
    Kiberd, B
    [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (7A) : S16 - S17
  • [9] Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: A retrospective study
    Baron, Pedro W.
    Ojogho, Okechukwu N.
    Yorgin, Peter
    Sahney, Shobha
    Cutler, Drew
    Ben-Youssef, Ramzi
    Baqai, Waheed
    Weissman, Jill
    Franco, Edson
    Zuppan, Craig
    Concepcion, Waldo
    [J]. PEDIATRIC TRANSPLANTATION, 2008, 12 (01) : 32 - 39
  • [10] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    [J]. TRANSPLANTATION, 2000, 69 (08) : S159 - S159
12345